SPPG have issued correspondence 19th March 2024 regarding the Living Well Service.
SUMMARY
The first campaign of 24/25 ‘Cancer Screening Saves Lives’ will commence 1st April 2024. The campaign aims to increase awareness of the cancer screening programmes available in NI.
Resources will be provided by 28th March 2024 and as per service specification, posters should be displayed in at least one window of the pharmacy.
NICPLD are hosting a webinar that is available to community pharmacists on 9th April 2024 at 7pm. Visit NICPLD website for more details.
PHA will be releasing social media posts in relation to this campaign and these can be shared on your channels. Details of the schedule is available on BSO website.
ACTION
Contractors are asked to read the correspondence issued by SPPG 19th March 2024 regarding the Living Well Service and share with all relevant members of the team.
If the resources for the first campaign ‘Cancer Screening Saves Lives’ are not received by 28th March 2024 email reception.pha@hscni.net immediately and ensure email subject is titled ‘LIVING WELL PHARMACY CAMPAIGN’. Failure to report this by 8th April 2024 will result in no resources being provided.
The current campaign ‘Know Your Units’ will finish on 31st March 2024 and the survey will run from 1st April until 6pm 29th April.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
This update contains important information for community pharmacy teams.
Correspondence has been issued by SPPG 14th March 2024 regarding the Community Pharmacy Assurance Framework.
SUMMARY
SPPG is seeking completion of the Community Pharmacy Assurance Framework (CPAF) declaration form for your pharmacy, for the 2023/24 year.
The aim and purpose of the framework is to monitor compliance with Terms of Service, service specifications, related professional standards and best practice guidance.
SPPG has recently worked with CPNI to review, update and agree the Assurance framework for the 2023/24 year.
A payment of £1200 will be made to each pharmacy, upon return of the completed declaration, for compliance with the CPAF process in 2023/24.
The recently resumed CPAF visits will continue, and pharmacies will be contacted directly if selected for a visit.
ACTION
Contractors are asked to review the correspondence and share with all relevant team members.
The declaration form must be completed no later than Wednesday 27th March 2024, and can be accessed by the following link.
A copy of the current practice leaflet and the complaints procedure/SOP should be submitted via email to your local office by 31st March 2024.
CPNI have produced a guidance document and resources to support you with CPAF, available on CPNI’s website HERE.
Please contact the Pharmacy Advisor at your local office for any queries.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
Dear Contractor
Important information regarding the Pharmacy First Sore Throat Pilot Service has been issued 14th March 2024 by SPPG.
SUMMARY
SPPG have issued the following correspondence 14th March 2024.
The letter confirms that the pilot sore throat service will end on 31st March 2024.
An evaluation of the service will be undertaken and the outcomes will inform the potential roll out of a similar service next winter.
An online survey will be shared with Community Pharmacy and GP practices, and the feedback from these surveys will be included in the evaluation process.
An online forum is also to be organised by SPPG to give pharmacists an opportunity to discuss what went well and areas needing improvement.
SPPG have contacted GP and OOHs informing them of the service end date.
ACTION
Contractors should read the correspondence issued 14th March 2024 by SPPG regarding Pharmacy First Sore Throat Pilot Service.
As the service is ending on 31st March 2024, contractors are encouraged to complete all outstanding claim forms and email them to your local office by Monday 8th April 2024 to ensure payment of fees.
All promotional materials should be removed from the pharmacy and any online platforms.
Please remind local GP practices that the service is coming to an end on 31st March 2024.
Complete the online evaluation survey once it becomes available.
Consider attending the online discussion forum that will be held in May.
Please share this information will all relevant team members.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
Dear Colleague
The Department of Health and Social Care (DHSC) has re-determined the February 2024 concessionary prices for the following medicines
Drug
Pack Size
Concessionary Price
Baclofen 10mg tablets
84
£4.33 (previously £2.78)
Etoricoxib 90mg tablets
28
£18.17 (previously £12.52)
Mometasone 50mcg/dose nasal spray
140
£9.47 (previously £4.60)
The improved prices will apply to prescriptions submitted for payment for the dispensing month of February 2024. Please note that these revised prices do not apply to March 2024 prescriptions. The first concessionary prices for March 2024 will be published soon.
Concessionary prices will be paid against the usual code, no additional endorsements are needed.
Please continue to notify CPNI of any pricing issues you are experiencing via our Medicine Shortage Reporter.
WhatsApp Business Terms of Service can be found here and privacy policy hereUCA-NI Privacy Policy We take your privacy seriously and do not share or sell any personal details with third parties for commercial purposes. If you have any questions, please contact the CPNI office. You can withdraw your consent to be contacted at any time by calling 028 9069 0444 or by emailing info@communitypharmacyni.co.uk. CPNI Data Protection Policy and Data Retention policy can be found Click Here
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
